Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 162 (RNA5SP162) is classified as a pseudogene, specifically a 5S rRNA pseudogene. Pseudogenes are segments of DNA that resemble functional genes but lack their coding or regulatory capacity due to accumulated sequence changes. The 5S rRNA pseudogenes originate from the 5S ribosomal RNA gene, which is a component of the ribosome involved in protein synthesis. However, RNA5SP162 does not produce a functional RNA or protein product and is not involved in any known biological pathway or disease mechanism. Pseudogenes like RNA5SP162 are generally regarded as non-functional "genomic fossils," although in rare cases, pseudogenes can exert regulatory effects on gene expression. No evidence suggests that RNA5SP162 has such functions nor that it is a direct target for drugs, a disease biomarker, or a therapeutic interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 162 (RNA5SP162).